Tag Archives: About

Bluebird CEO defends $1.8 million gene therapy price — ‘It’s really thinking about it differently’

Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $ 1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for patients with beta thalassemia who require regular blood transfusions to manage their disease and have no… Read More »

What to know about low urine output

Low urine output is a symptom that people who are sick and have lost too many liquids commonly experience. It also occurs in people who have an obstruction in their urinary tract. However, the body may produce less urine for several different reasons, which will require different treatments. Oliguria is the medical term for low… Read More »